| $385M | ||
| $350M | ||
| $215M | ||
| $88M | ||
| $82M | ||
| $62M |
Buys | $0 | 1 | 100 |
Sells | $0 | 0 | 0 |
| DO CUONG V | President & CEO | 1 | $0 | 0 | $0 | $0 |
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in pre-clinical stage for the treatment of multiple myeloma and prostate cancer. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is based in Carson City, Nevada.
Over the last 12 months, insiders at BioVie Inc. have bought $0 and sold $0 worth of BioVie Inc. stock.
On average, over the past 5 years, insiders at BioVie Inc. have bought $9,650 and sold $352,703 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,000 shares for transaction amount of $0 was made by DO CUONG V (President & CEO) on 2025‑08‑07.
| 2025-08-07 | DO CUONG V | President & CEO | 5,000 – | $0 | $0 | -46.74% | ||
| 2024-03-04 | DO CUONG V | President & CEO | 10,000 0.0236% | $1.00 | $10,000 | -71.31% | ||
| 2023-12-01 | Sale | GORLIN STEVE | director | 75,680 0.2029% | $1.69 | $127,899 | -72.15% | |
| 2023-11-30 | DO CUONG V | President & CEO | 10,000 0.0263% | $1.78 | $17,800 | -73.92% | ||
| 2023-09-05 | Sale | GORLIN STEVE | director | 8,560 0.023% | $3.05 | $26,108 | -74.26% | |
| 2023-08-22 | Sale | BERMAN RICHARD J | director | 10,805 0.0289% | $3.50 | $37,827 | -70.51% | |
| 2023-06-07 | Sale | BERMAN RICHARD J | director | 5,984 0.017% | $5.81 | $34,782 | -69.90% | |
| 2023-05-22 | Sale | BERMAN RICHARD J | director | 5,000 0.0137% | $6.50 | $32,506 | -54.90% | |
| 2023-03-28 | Sale | BERMAN RICHARD J | director | 7,613 0.0213% | $8.52 | $64,870 | -59.33% | |
| 2023-03-27 | Sale | BERMAN RICHARD J | director | 3,371 0.0096% | $8.52 | $28,711 | -58.32% | |
| 2021-12-07 | KIM JOANNE WENDY | CFO | 2,000 0.0084% | $5.40 | $10,798 | -38.99% | ||
| 2020-11-03 | GORLIN STEVE | director | 2,430 0.0171% | $7.95 | $19,319 | +78.22% | ||
| 2020-10-30 | GORLIN STEVE | director | 2,570 0.0185% | $7.97 | $20,483 | +81.68% | ||
| 2020-10-21 | GORLIN STEVE | director | 5,000 0.0362% | $9.19 | $45,950 | +58.95% | ||
| 2020-10-15 | GORLIN STEVE | director | 15,100 0.1065% | $10.10 | $152,517 | +40.72% | ||
| 2020-10-09 | GORLIN STEVE | director | 282 0.002% | $9.61 | $2,710 | +50.83% | ||
| 2020-10-07 | GORLIN STEVE | director | 4,718 0.0343% | $9.42 | $44,444 | +55.36% | ||
| 2020-09-22 | GORLIN STEVE | director | 15,000 0.263% | $10.00 | $150,000 | +51.62% |
| Increased Positions | 12 | +27.91% | 694,684 | +88.9% |
| Decreased Positions | 15 | -34.88% | 76,260 | -9.76% |
| New Positions | 7 | New | 576,527 | New |
| Sold Out Positions | 7 | Sold Out | 9,913 | Sold Out |
| Total Postitions | 40 | -6.98% | 1M | +79.14% |
| Diametric Capital, Lp | $492.00 | 4.63% | 370,000 | +370,000 | New | 2025-09-30 |
| Prelude Capital Management, Llc | $193.00 | 1.81% | 144,762 | +144,762 | New | 2025-09-30 |
| Prosperity Wealth Management, Inc. | $191.00 | 1.79% | 143,500 | +143,500 | New | 2025-09-30 |
| Vanguard Group Inc | $171.00 | 1.61% | 128,932 | +73,695 | +133.42% | 2025-09-30 |
| Citadel Advisors Llc | $139.00 | 1.31% | 104,531 | +104,531 | New | 2025-09-30 |
| Philadelphia Trust Co | $100.00 | 0.94% | 75,010 | +75,010 | New | 2025-09-30 |
| Renaissance Technologies Llc | $97.00 | 0.91% | 72,918 | +72,918 | New | 2025-09-30 |
| Geode Capital Management, Llc | $70.00 | 0.66% | 52,374 | +38,434 | +275.71% | 2025-09-30 |
| Squarepoint Ops Llc | $44.00 | 0.42% | 33,294 | +33,294 | New | 2025-09-30 |
| Two Sigma Investments, Lp | $43.00 | 0.41% | 32,505 | +32,505 | New | 2025-09-30 |